CatalystPit

AZNASTRAZENECA PLC

NYSE · Pharmaceutical Preparations
Last close $160.12 · 2026-10-07
ABOUT
ExchangeNYSE
SectorHealthcare
IndustryPharmaceutical Preparations
RECENT INSIDER TRADES
  • 2026-10-08 · Sharma Mani (See remarks) · OTHER
  • 2026-09-11 · Sharma Mani (See Remarks) · OTHER
  • 2026-09-11 · Sharma Mani (See Remarks) · BUY
  • 2026-08-07 · Sharma Mani (SVP, Group Controller) · OTHER
  • 2026-07-08 · Sharma Mani (See Remarks) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders306
Shares held318,245,704
Value$58.55B
As of quarter end2026-06-30
RECENT CONGRESSIONAL TRADES
  • 2026-03-31 · Alan Armstrong · BUY · $1,001 - $15,000
  • 2026-03-30 · Alan Armstrong · BUY · $15,001 - $50,000
RECENT NEWS
  • Myriad, SOPHiA partner with AstraZeneca to use prostate cancer technology
  • AstraZeneca CEO Soriot says drugmaker can grow without big acquisition
  • AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment
  • AstraZeneca to invest over $1 billion in Massachusetts, boost workforce
  • SERD Market Set for Growth During the Forecast Period (2026-2036) as AstraZeneca's ETCAMAH Approval Accelerates Adoption of Oral SERDs
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS